Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in the borough of Manhattan in New York City, founded in 1884 as the New York Cancer Hospital.

There are 498 (2018) beds in Memorial Sloan Kettering Cancer Center; Clinical Trials Office.

During the past decade, Memorial Sloan Kettering Cancer Center; Clinical Trials Office conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Sloan Kettering Cancer Center; Clinical Trials Office" #1 collaborator was "AbbVie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan Kettering Cancer Center; Clinical Trials Office" are "Chronic Lymphocytic Leukemia" (1 trials), "Myelogenous Leukemia, Chronic" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Memorial Sloan Kettering Cancer Center; Clinical Trials Office" in a lesser frequency.

Most popular intervention types in "Memorial Sloan Kettering Cancer Center; Clinical Trials Office" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bendamustine" (1 trials), "PF-06671008" (1 trials), "Rituximab" (1 trials), "Venetoclax" (1 trials) and "imatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan Kettering Cancer Center; Clinical Trials Office" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Memorial Sloan Kettering Cancer Center; Clinical Trials Office". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Memorial Sloan Kettering Cancer Center; Clinical Trials Office, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan Kettering Cancer Center; Clinical Trials Office, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".